OREANDA-NEWS. Astellas Pharma Inc. (President and CEO: Yoshihiko Hatanaka) today announced the personnel changes and organizational changes as below.

1. Appointment of Senior Corporate Executive effective on April 1, 2016

Name New Title Current Title
Masao Yoshida CEO's Office President, Americas Operations

2. Appointments of Corporate Executive effective on April 1, 2016

Name New Title Current Title
Shouji Yokota CEO's Office Divisional Senior Vice President, Technology Product Management, Technology
Takahisa Iizuka CEO's Office Divisional Senior Vice President, Sales Operation, Japan Sales & Marketing
Chihiro Yokota Head of Japan/Asia Development, Development Head of Japan/Asia Development, Development and Head of Medical Affairs, Japan
Atsushi Kamide Vice President, Healthcare Policy & CSR Divisional Senior Vice President, Product Marketing, Japan Sales & Marketing
Kiyotaka Hayashi Divisional Senior Vice President, Sales Operation, Japan Sales & Marketing General Manager, Osaka Branch, Japan Sales & Marketing
Chikashi Takeda Corporate Vice President, Corporate Finance & Control Corporate Vice President, Corporate Planning

3. Resignation of Senior Corporate Executive effective on June 20, 2016

Name Title (effective on April 1, 2016)
Masao Yoshida CEO's Office

4. Resignations of Corporate Executive effective on June 20, 2016

Name Title (effective on April 1, 2016)
Shouji Yokota CEO's Office
Takahisa Iizuka CEO's Office

5. New Corporate Executives effective on June 20, 2016

Name Title (effective on April 1, 2016)
Naoki Okamura Corporate Vice President, Corporate Planning
Takuya Oshida Senior Vice President, Head of Medical Affairs, Japan
Yasuhiro Kanzaki General Manager, Osaka Branch, Japan Sales & Marketing

6. Personnel Changes effective on April 1, 2016
Name New Title Current Title
James Robinson President, Americas Operations President, Astellas Pharma US, Inc.
Kunihiko Kokubo Head of Quality Assurance Vice President, Quality Assurance, Japan, Asia & Oceania
Takuya Oshida Head of Medical Affairs, Japan Vice President, Medical Science, Medical Affairs, Japan
Naoki Okamura Corporate Vice President, Corporate Planning Corporate Vice President, Business Development
Jun Kono Corporate Vice President, Business Development Vice President, Corporate Strategy & Communications, EMEA
Koichiro Morihira Vice President, Intellectual Property Executive Director, Intellectual Property
Motoi Aoki Vice President, Quality Assurance, Japan, Asia & Oceania Senior Director, Quality Assurance, EMEA
Aiji Miyashita Vice President, Clinical and Research Quality Assurance Senior Director, Analysis & Pharmacokinetics Research Labs., Drug Discovery Research
Akira Unami Vice President, Drug Safety Research Labs., Drug Discovery Research Senior Director, Drug Safety Research Labs., Drug Discovery Research
Hideki Maeda Vice President, Medical Science, Medical Affairs, Japan Vice President, Medical Research, Medical Affairs, Japan
Yasushi Ikeda Vice President, Medical Research, Medical Affairs, Japan Senior Director, Medical Science, Medical Affairs, Japan
Naoko Sato Vice President, Medical Communications, Japan, Medical Affairs, Japan Vice President, Medical Information Center, Medical Affairs, Japan
Katsutoshi Nakamura Vice President, Technology Product Management, Technology Executive Director, Technology Product Management, Technology
Shigeru Ieda Vice President, Process Chemistry Labs., Technology General Manager, Astellas Pharma Tech Co., Ltd.
Shiro Yamamoto Divisional Senior Vice President, Product Marketing, Japan Sales & Marketing Executive Director, Product Marketing, Japan Sales & Marketing
Akihiro Takimoto Vice President, Distribution Relations, Japan Sales & Marketing Senior Director, Distribution Relations, Japan Sales & Marketing
Norihito Matsunami General Manager, Sapporo Branch, Japan Sales & Marketing Senior Director, Nagoya Branch, Japan Sales & Marketing
Masayuki Ohki General Manager, Kanetsu Branch, Japan Sales & Marketing General Manager, Yokohama Branch, Japan Sales & Marketing
Sakakiya Hiroshi General Manager, Yokohama Branch, Japan Sales & Marketing Executive Director, Kobe Branch, Japan Sales & Marketing
Yasuhiro Kanzaki General Manager, Osaka Branch, Japan Sales & Marketing General Manager, Sapporo Branch, Japan Sales & Marketing

7. Personnel Changes of Affiliates effective on April 1, 2016

Name
New Title
Current Title
Akira Sekine
President, Astellas Learning Institute Co., Ltd.
Executive Director, Human Resources Astellas Pharma Inc.
Ryoichi Uematsu
President, Astellas Analytical Science Laboratories, Inc.
Senior Director, Technology Planning & Administration, Technology Astellas Pharma Inc.

8. Appointment of Staff Executive Director effective on April 1, 2016

Name New Title Current Title
Mineo Takahashi Staff Executive Director, Japan Sales & Marketing Vice President, Distribution Relations, Japan Sales & Marketing

9. Organizational Changes effective on April 1, 2016

Healthcare Policy & CSR

A corporate division, Healthcare Policy & CSR, will be newly established by consolidating functions responsible for taking actions to improve patient access to health care. Vice President of Healthcare Policy & CSR will report to Chief Strategy Officer.

Medical Information Center

The name of Medical Information Center will be changed to Medical Communications, Japan.

About Astellas
Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. We focus on Urology, Oncology, Immunology, Nephrology and Neuroscience as prioritized therapeutic areas while advancing new therapeutic areas and discovery research leveraging new technologies/modalities. We are also creating new value by combining internal capabilities and external expertise in the medical/healthcare business. Astellas is on the forefront of healthcare change to turn innovative science into value for patients.